Skip to main content

GenTel Receives $1.2M NIH Grant to Develop Protein Chip for Allergy Diagnostics

NEW YORK, May 22 (GenomeWeb News) - The National Institutes of Health awarded GenTel BioSciences a two-year, $1.2-million grant to develop a protein chip that can diagnose respiratory allergies, the company said today.

 

The test kit will use a few drops of blood to identify patient allergies, Bryce Nelson, GenTel's vice president of R&D, said in a statement. The chip will use multiplex assays to rapidly test a patient's blood against several potential allergies at once.

 

GenTel hopes the test will replace puncture tests, where extracts are inserted under the patient's skin in multiple punctures. Existing alternatives include venous blood draws, which require sizeable amounts of blood and have a slow turnaround time for results.

 

As part of the Phase II SBIR grant, GenTel plans to place beta-testing instruments in doctor's offices in the second year of the project.

 

GenTel has received six SBIR awards, totaling over $2 million, in the last three years. In 2005, the company completed a Phase I SBIR on an allergy chip concept.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.